THE EFFECT OF MERATRAN ON TWENTY-FIVE INSTITUTIONALIZED MENTAL PATIENTS
J. W. SCHUT M. D., and
H. E. HIMWICH M. D.
A study was conducted on 25 institutionalized psychotic patients with chronic courses, selected because of their depressive and/or regressive symptoms.
Meratran was found to be a central nervous system stimulant useful in the field of psychiatry and with certain indications and contraindications: (1) indications: (a) schizophrenics without delusions having restriction of interest and activity and with depressant features, (b) psycho-motor retardation and/or blocking of communication, (c) long-term hospitalized schizophrenics with severe deterioration; (2) contraindications: (a) patients with delusions, (b) patients with anxiety, (c) disturbed patients with cerebral arteriosclerosis.
